Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

January 01, 1985; Volume 13,Issue 1
  • You have access
    Brain uptake of flurazepam and of N1-desalkyl flurazepam after administration of flurazepam to the cat.
    C C Chiueh, M Ohata, L A Jonas, D J Greenblatt and S I Rapoport
    Drug Metabolism and Disposition January 1985, 13 (1) 1-4;
  • You have access
    Stereoselective glucuronidation as a probe of induced forms of UDP-glucuronyltransferase in rabbits.
    G S Yost and B L Finley
    Drug Metabolism and Disposition January 1985, 13 (1) 5-8;
  • You have access
    Effects of somatostatin and testosterone on the hepatic monooxygenase system in castrated male rats.
    B B Virgo
    Drug Metabolism and Disposition January 1985, 13 (1) 9-13;
  • You have access
    Aging effects on acetaminophen toxicity and glutathione status in the mosquito.
    J P Richie and C A Lang
    Drug Metabolism and Disposition January 1985, 13 (1) 14-17;
  • You have access
    Disposition of benzo(f)quinoline in male rats.
    L S Birnbaum and L Johnson
    Drug Metabolism and Disposition January 1985, 13 (1) 18-24;
  • You have access
    Disposition and metabolic fate of 14C-quazepam in man.
    N Zampaglione, J M Hilbert, J Ning, M Chung, R Gural and S Symchowicz
    Drug Metabolism and Disposition January 1985, 13 (1) 25-29;
  • You have access
    A radiometric method for the measurement of adenosine 3'-phosphate 5'-phosphosulfate in rat and mouse liver.
    G A Hazelton, J J Hjelle, R L Dills and C D Klaassen
    Drug Metabolism and Disposition January 1985, 13 (1) 30-34;
  • You have access
    Acetaminophen decreases adenosine 3'-phosphate 5'-phosphosulfate and uridine diphosphoglucuronic acid in rat liver.
    J J Hjelle, G A Hazelton and C D Klaassen
    Drug Metabolism and Disposition January 1985, 13 (1) 35-41;
  • You have access
    Metabolism of acetaminophen and phenacetin by isolated rat hepatocytes. A system in which the spatial organization inherent in the liver is disrupted.
    K S Pang, P Kong, J A Terrell and R E Billings
    Drug Metabolism and Disposition January 1985, 13 (1) 42-50;
  • You have access
    Formation of [20R]-dihydrodigoxin from digoxin in humans.
    R H Reuning, T A Shepard, B E Morrison and H N Bockbrader
    Drug Metabolism and Disposition January 1985, 13 (1) 51-57;
  • You have access
    Loss of rat liver microsomal cytochrome P-450 during methimazole metabolism. Role of flavin-containing monooxygenase.
    G L Kedderis and D E Rickert
    Drug Metabolism and Disposition January 1985, 13 (1) 58-61;
  • You have access
    Age-related changes in glucuronidation and deglucuronidation in liver, small intestine, lung, and kidney of male Fischer rats.
    S J Borghoff and L S Birnbaum
    Drug Metabolism and Disposition January 1985, 13 (1) 62-67;
  • You have access
    Increased UDP-glucuronosyltransferase activity and UDP-glucuronic acid concentration in the small intestine of butylated hydroxyanisole-treated mice.
    J J Hjelle, G A Hazelton and C D Klaassen
    Drug Metabolism and Disposition January 1985, 13 (1) 68-70;
  • You have access
    Metabolites of phenanthridine formed by rat liver homogenate.
    E J LaVoie, E A Adams, A Shigematsu and D Hoffmann
    Drug Metabolism and Disposition January 1985, 13 (1) 71-75;
  • You have access
    Metabolism of 7,12-dimethylbenz(a)anthracene and its DNA adduct formation in human fetal kidney and intestinal cells in culture.
    C T Oravec, M J Samuel and S M D'Ambrosio
    Drug Metabolism and Disposition January 1985, 13 (1) 76-80;
  • You have access
    Studies on the biotransformation in the perfused rat liver of 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediates.
    A W Rettenmeier, K S Prickett, W P Gordon, S M Bjorge, S L Chang, R H Levy and T A Baillie
    Drug Metabolism and Disposition January 1985, 13 (1) 81-96;
  • You have access
    The area under the curve of metabolites for drugs and metabolites cleared by the liver and extrahepatic organs. Its dependence on the administration route of precursor drug.
    P J Klippert and J Noordhoek
    Drug Metabolism and Disposition January 1985, 13 (1) 97-101;
  • You have access
    Kinetics of receptor occupation and anticonvulsive effects of diazepam in rats.
    Y Igari, Y Sugiyama, Y Sawada, T Iga and M Hanano
    Drug Metabolism and Disposition January 1985, 13 (1) 102-106;
  • You have access
    4,5-beta-dihydrotestolactone: metabolite identification with the aid of the attached proton test in carbon-13 NMR.
    R L Yeager, V L Pascucci, D C Chatterji and B A Mico
    Drug Metabolism and Disposition January 1985, 13 (1) 107-109;
  • You have access
    Stability of acyl glucuronides in blood, plasma, and urine: studies with zomepirac.
    P C Smith, J Hasegawa, P N Langendijk and L Z Benet
    Drug Metabolism and Disposition January 1985, 13 (1) 110-112;
  • You have access
    In vitro and in vivo metabolism of a radioiodinated analog of 1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,-dichloroethane.
    R C Pohland and R E Counsell
    Drug Metabolism and Disposition January 1985, 13 (1) 113-115;
  • You have access
    Release of fluoride ion from 5'-deoxy-5-fluorouridine, an antineoplastic fluoropyrimidine, in humans.
    R Martino, A Lopez, M C Malet-Martino, J Bernadou and J P Armand
    Drug Metabolism and Disposition January 1985, 13 (1) 116-118;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 13, Issue 1
1 Jan 1985
  • Table of Contents
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Cannabinoid Metabolites as CYP450 Inhibitors
  • Physiology of the Neonatal Gastrointestinal System
  • Pharmacokinetics and Disposition of Biologics
  • Switch from CAR to PXR in the Presence of EGF
  • Alternative P450 Splicing Redirects Human Drug Metabolism
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics